1006865-29-7

Upstream product

• 911855-78-2 (R)-3-methoxy-2-methyl-propan-1-ol 
• 1006865-31-1 1-benzyl-4-[4-((S)-3-methoxy-2-methyl-propoxymethyl)-phenyl]-3-(R,S)-trityloxy-methyl-piperidin-4-(R,S)-ol 
• 1006865-30-0 1-benzyl-4-[4-((S)-3-methoxy-2-methyl-propoxy-methyl)-phenyl]-3-(R,S)-trityloxymethyl-1,2,3,6-tetrahydro-pyridine 
• 1006865-32-2 1-bromo-4-((S)-3-methoxy-2-methyl-propoxymethyl)-benzene 
• 1006901-40-1 1-benzyl-4-[4-((S)-3-methoxy-2-methyl-propoxymethyl)-phenyl]-5-trityloxymethyl-piperidin-3-ol 

Relevant academic research and scientific papers

SUBSTITUTED PIPERIDINES AS THERAPEUTIC COMPOUNDS

Described are compounds of the general formula (I), and pharmaceutically acceptable salt thereof, in which R1 has the definitions illustrated in detail in the description, as beta-secretase, cathepsin D, plasmepsin II and/or HIV protease inhibi

NITRATE ESTERS OF PIPERIDINES

The application relates to novel nitrate ester derivatives of substituted piperidines of the general formula (I), wherein R1, R2, R3, X, Y and Z0, and m, n, p and q have the meanings explained in more detail in